Investigating omega-3 fatty acids for treating TMD pain.
PUFA metabolism for prevention and treatment of TMD pain: an interdisciplinary, translational approach.
This study is looking at how omega-3 fatty acids might help reduce pain from jaw issues like temporomandibular disorder (TMD), and it’s for people who experience this kind of pain to help find new, gentle treatment options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10820840 on NIH RePORTER |
What this research studies
This research focuses on how omega-3 dietary polyunsaturated fatty acids (n-3 PUFAs) can help manage and prevent pain associated with temporomandibular disorder (TMD). The study aims to explore the anti-inflammatory and pain-relieving properties of these fatty acids, particularly through their derivatives known as specialized proresolving lipid mediators. By analyzing patient data and utilizing advanced imaging and machine learning techniques, the research seeks to develop new, non-invasive treatment options for TMD and its related conditions. Patients may be involved in the research to help identify effective interventions based on their experiences and outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from temporomandibular disorder (TMD) and related pain conditions.
Not a fit: Patients who do not have TMD or related pain conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative, non-invasive treatments for managing TMD pain and improving patients' quality of life.
How similar studies have performed: Previous research has shown promising results in using omega-3 fatty acids for pain management, indicating potential success for this approach.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Slade, Gary Douglas — Univ of North Carolina Chapel Hill
- Study coordinator: Slade, Gary Douglas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.